| __timestamp | Merck & Co., Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 31354781 |
| Thursday, January 1, 2015 | 6704000000 | 43445817 |
| Friday, January 1, 2016 | 7194000000 | 66489820 |
| Sunday, January 1, 2017 | 9982000000 | 96886134 |
| Monday, January 1, 2018 | 9752000000 | 153793000 |
| Tuesday, January 1, 2019 | 9872000000 | 148369000 |
| Wednesday, January 1, 2020 | 13397000000 | 151934000 |
| Friday, January 1, 2021 | 12245000000 | 198532000 |
| Saturday, January 1, 2022 | 13548000000 | 112128000 |
| Sunday, January 1, 2023 | 30531000000 | 76192000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Merck & Co., Inc. has consistently outpaced TG Therapeutics, Inc. in R&D investment. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at an impressive $30 billion in 2023. In contrast, TG Therapeutics, a smaller player, saw its R&D spending grow by approximately 140% during the same period, reaching nearly $200 million in 2021 before declining.
This stark contrast highlights the differing scales and strategies of these companies. While Merck leverages its vast resources to maintain a leading edge in drug development, TG Therapeutics focuses on niche markets with targeted investments. As the pharmaceutical landscape evolves, these R&D trends will be crucial in shaping the future of healthcare innovation.
Comparing Innovation Spending: Merck & Co., Inc. and Bristol-Myers Squibb Company
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Merck & Co., Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Merck & Co., Inc. vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Wave Life Sciences Ltd.
Comparing Innovation Spending: Merck & Co., Inc. and Galapagos NV
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and TG Therapeutics, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs TG Therapeutics, Inc.
R&D Spending Showdown: TG Therapeutics, Inc. vs HUTCHMED (China) Limited
Comparing Innovation Spending: TG Therapeutics, Inc. and Supernus Pharmaceuticals, Inc.